Henning Lauterbach

1.9k total citations
34 papers, 1.5k citations indexed

About

Henning Lauterbach is a scholar working on Immunology, Genetics and Infectious Diseases. According to data from OpenAlex, Henning Lauterbach has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 16 papers in Genetics and 14 papers in Infectious Diseases. Recurrent topics in Henning Lauterbach's work include Immunotherapy and Immune Responses (19 papers), Virus-based gene therapy research (15 papers) and Viral Infections and Outbreaks Research (13 papers). Henning Lauterbach is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Virus-based gene therapy research (15 papers) and Viral Infections and Outbreaks Research (13 papers). Henning Lauterbach collaborates with scholars based in Switzerland, United States and Germany. Henning Lauterbach's co-authors include Hubertus Hochrein, Shizuo Akira, Meredith O’Keeffe, Christian A. Luber, Mark Suter, Jürg Tschopp, Jürgen Cox, Marian Wiegand, Ben Fancke and Matthias Selbach and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Henning Lauterbach

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henning Lauterbach Switzerland	15	868	494	287	170	168	34	1.5k
Mathieu Houde Canada	16	772 0.9×	591 1.2×	325 1.1×	110 0.6×	133 0.8×	18	1.6k
Leo Kei Iwai Brazil	21	201 0.2×	488 1.0×	347 1.2×	147 0.9×	104 0.6×	61	1.2k
Pernille Andersen Denmark	12	415 0.5×	930 1.9×	126 0.4×	107 0.6×	99 0.6×	15	1.5k
Michael F. Princiotta United States	19	1.6k 1.8×	1.2k 2.5×	456 1.6×	185 1.1×	236 1.4×	34	2.7k
Scott S. Terhune United States	25	424 0.5×	647 1.3×	1.3k 4.5×	192 1.1×	194 1.2×	60	1.9k
Fiona Greer United Kingdom	12	532 0.6×	404 0.8×	157 0.5×	106 0.6×	77 0.5×	17	1.1k
Daniel Degrandi Germany	19	1.0k 1.2×	991 2.0×	593 2.1×	80 0.5×	176 1.0×	34	2.1k
L. Edelman France	23	446 0.5×	838 1.7×	206 0.7×	211 1.2×	310 1.8×	53	2.0k
Rosaura Hernández‐Rivas Mexico	21	761 0.9×	864 1.7×	301 1.0×	147 0.9×	240 1.4×	60	2.2k
Michael Dolan United States	22	274 0.3×	673 1.4×	263 0.9×	93 0.5×	377 2.2×	52	1.3k

Countries citing papers authored by Henning Lauterbach

Since Specialization

Citations

This map shows the geographic impact of Henning Lauterbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Lauterbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Lauterbach more than expected).

Fields of papers citing papers by Henning Lauterbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henning Lauterbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Lauterbach. The network helps show where Henning Lauterbach may publish in the future.

Co-authorship network of co-authors of Henning Lauterbach

This figure shows the co-authorship network connecting the top 25 collaborators of Henning Lauterbach. A scholar is included among the top collaborators of Henning Lauterbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Lauterbach. Henning Lauterbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinto, Catarina, Mohamed Habbeddine, Sandra Rosskopf, et al.. (2024). Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for ImmunoTherapy of Cancer. 12(4). e008286–e008286. 4 indexed citations

Fernández-Sendin, Myriam, Maite Álvarez, Fernando Aranda, et al.. (2024). Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for ImmunoTherapy of Cancer. 12(4). e008287–e008287. 2 indexed citations

Sharma, Bhawna, Elena Bekerman, Hoa Truong, et al.. (2024). Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates. Vaccines. 12(7). 735–735. 1 indexed citations

Schmidt, Sarah, Stéphane Daffis, Adrian Tomkinson, et al.. (2023). Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus–Specific CD8 T-Cell Responses and High Anti–Hepatitis B Surface Antigen Titers. The Journal of Infectious Diseases. 229(4). 1077–1087. 4 indexed citations

Boopathy, Archana V., Bhawna Sharma, Silpa Suthram, et al.. (2023). Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys. npj Vaccines. 8(1). 175–175. 3 indexed citations

Hinterberger, Maria, Kathrin Endt, Barbara Bathke, et al.. (2023). Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication. Scientific Reports. 13(1). 5162–5162. 1 indexed citations

Hinterberger, Maria, Barbara Bathke, Sonia Wennier, et al.. (2021). Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory. Journal for ImmunoTherapy of Cancer. 9(2). e001586–e001586. 16 indexed citations

Stutte, Susanne, Hellen Ishikawa‐Ankerhold, Peggy Marconi, et al.. (2021). Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice. Brain Behavior and Immunity. 95. 429–443. 8 indexed citations

Lauterbach, Henning, Sarah Schmidt, Xiaoping Qing, et al.. (2021). Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform. Frontiers in Oncology. 11. 732166–732166. 15 indexed citations

10.

Sanos, Stéphanie L., Barbara Bathke, Kay Brinkmann, et al.. (2018). NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin. Frontiers in Immunology. 8. 1988–1988. 12 indexed citations

11.

Bathke, Barbara, Maria Hinterberger, Kay Brinkmann, et al.. (2017). CD70 encoded by modified vaccinia virus Ankara enhances CD8 T‐cell‐dependent protective immunity in MHC class II‐deficient mice. Immunology. 154(2). 285–297. 3 indexed citations

12.

Lauterbach, Henning, Barbara Bathke, Kay Brinkmann, et al.. (2013). Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity. Frontiers in Immunology. 4. 251–251. 12 indexed citations

13.

Oldenburg, Marina, Anne Krüger, Ruth Ferstl, et al.. (2012). TLR13 Recognizes Bacterial 23 S rRNA Devoid of Erythromycin Resistance–Forming Modification. Science. 337(6098). 1111–1115. 320 indexed citations

14.

Luber, Christian A., Jürgen Cox, Henning Lauterbach, et al.. (2010). Quantitative Proteomics Reveals Subset-Specific Viral Recognition in Dendritic Cells. Immunity. 32(2). 279–289. 479 indexed citations

15.

Hausmann, Jürgen, Henning Lauterbach, Michaela Schmidt, et al.. (2008). Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. Journal of Clinical Investigation. 118(5). 1776–1784. 114 indexed citations

16.

Lauterbach, Henning, et al.. (2007). Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification. Virology Journal. 4(1). 53–53. 15 indexed citations

17.

Lauterbach, Henning, et al.. (2006). Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. The Journal of Experimental Medicine. 203(8). 1963–1975. 50 indexed citations

18.

Lauterbach, Henning, et al.. (2006). Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination. The Journal of Immunology. 176(8). 4600–4607. 38 indexed citations

19.

Lauterbach, Henning, Christine Ried, Alberto L. Epstein, Peggy Marconi, & Thomas Brocker. (2005). Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. Journal of General Virology. 86(9). 2401–2410. 40 indexed citations

20.

Lauterbach, Henning, Kristen M. Kerksiek, Dirk H. Busch, et al.. (2004). Protection from Bacterial Infection by a Single Vaccination with Replication-Deficient Mutant Herpes Simplex Virus Type 1. Journal of Virology. 78(8). 4020–4028. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact